CL2A (TFA)

Product Description: CL2A TFA is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A TFA is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker[1].

Applications: Cancer-programmed cell death

Formula: C52H80F3N9O18

References: [1]Samantha Congreve, et al. Antibody drug conjugates (ADC). Teknisk- naturvetenskaplig fakultet

Molecular Weight: 1176.24

Compound Purity: 99.49

Research Area: Cancer; Inflammation/Immunology

Target: ADC Linker

• SKU: MEXHY-128945A-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-128945A-5
• Package Unit: 5 mg
• Quantity Unit: STK